姬峻芳浙江大学生命科学研究院生物学细胞生物学；分子肿瘤学个人简介:教育及工作经历：1995.09-2000.07     医学学士，中国山西医科大学，临床医学系2000.09-2003.07     医学硕士，中国郑州大学医学院，消化医学2003.09-2006.07     理学博士，中国中国协和医科大学，细胞生物学2006.09-2011.09     博士后，美国国立卫生研究院国家癌症研究所2011.09-2013.09     Research Fellow， 美国国立卫生研究院国家癌症研究所2013.09-2015.03     助理教授，美国夏威夷大学癌症中心2015.03-今              教授，中国浙江大学生命科学研究院0学术荣誉：2016   浙江省千人计划2015   浙江省151人才工程2013   National Cancer Institute Certificate of Appreciation，美国国家癌症研究所2012   华夏医学科技奖(一等奖)2012   Outstanding Postdoctoral Fellow Award National Cancer Institute USA2012   Fellows Award for Research Excellence  National Institutes of Health USA   2009   Federal Technology Transfer Award  National Institutes of Health USA  2009   北京市科学技术奖（二等奖）2009   高等学校科学研究优秀成果奖（科学技术）(一等奖 )2008   Federal Technology Transfer Award  National Institutes of Health USA   2008   Fellows Award for Research Excellence National Institutes of Health USA   国际学术组织兼职：           2011-今，    美国癌症研究协会，会员2010-今，    美洲华人生物科学学会，会员2011-2012，  欧洲肝癌研究协会，会员2013-2014，  美国肝脏疾病研究协会，会员2012-今，    Frontiers in Cancer Molecular Targets and Therapeutics，期刊编委2013-今，    Frontiers in Molecular Medicine，期刊编委2013-今，    Stem Cell Investigation，期刊编委22015-2016    全球肝癌会议 主席2016-今      北京亚太肝病诊疗技术联盟远程肝病学院全国会诊专家2017-今，    中国抗癌协会肿瘤精准治疗专业委员会，委员教学与课程:栏目建设中....科研:研究领域：microRNA与肝细胞癌 主要研究方向：microRNA在肝癌的肿瘤异质性中的分子机制及其临床应用。 主要研究内容：我们将着眼于肝癌的肿瘤异质性，研究microRNA 在肝癌肿瘤异质性中的角色，深入寻找、鉴定并分析不同肝癌亚型，检测各亚型的microRNA 分子标志物及特异信号传导通路，研究microRNA的生物学功能，并揭示其在肝癌的早期临床诊断、预后和精准治疗中的的临床应用价值。 主要研究方法：细胞生物学、分子生物学、生物信息学、实验动物学等方法。 主要成就：于microRNA与肝细胞癌研究领域的具有国际影响力杂志上发表文章30余篇，其中以第一作者或通讯作者发表论文17篇。部分研究成果发表在国际一流学术期刊上，如New England Journal of Medicine（新英格兰）。单篇最高影响因子51.66，共引用次数达1000次以上。参与英文著作出版3篇。拥有美国国家专利2项。概述如下：首次揭示1)高表达EpCAM和AFP的肝癌细胞是肝癌干细胞，wnt/beta-catenin/miR-181/ EpCAM信号传导通路在这一群细胞中异常激活，同时miR-181以及EpCAM在具有肝癌干细胞特征的病人中具有潜在临床治疗价值； 2)miR-26在男性和女性肝癌患者中表达差异显著，具有抑制肿瘤发生发展的作用，miR-26表达降低的病人对术后干扰素治疗疗效显著，目前已建立临床标准化miR-26DX检测用于指导术后干扰素治疗并进入第三期临床试验；3)microRNA在不同诱因导致的肝癌以及不同肝癌亚型中具有显著不同的抑癌或促癌功能，如：miR-375特异显著抑制Ras诱发的肝癌；let-7g 具有重要的抑制肝癌转移的功能等。研究与成果:代表性论文2017年： 1.    Xie G Wang X Zhao A Yan J Chen W Jiang R Ji J Huang F Zhang Y Lei S Ge K Zheng X Rajani C Alegado RA Liu J Liu P Nicholson J Jia W. Sex-dependent effects on gut microbiota regulate hepatic carcinogenic outcomes. Sci Rep. 2017 Mar 27;7:45232. doi: 10.1038/srep45232. 2.    Guo X Zhao Y Yan H Yang Y Shen S Dai X Ji X Ji F Gong XG Li L Bai X Feng XH Liang T Ji J Chen L Wang H Zhao B. Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. Genes Dev. 2017 Feb 1;31(3):247-259. doi: 10.1101/gad.294348.116. 3.    Sun Y* Ji F* Kumar MR* Zheng X Xiao Y Liu N Shi J Wong L Forgues M Qin LX Tang ZY Zhao X Wang XW# Ji J#. Transcriptome integration analysis in hepatocellular carcinoma reveals discordant intronic miRNA-host gene pairs in expression. International Journal of Biological Sciences. 2017 In press.4.     Xue R Li J Bai F Wang XW Ji J# Lu Y#. A Race to uncover a panoramic view of the liver cancer genome. Cancer Biol Med. 2017 In press doi: 10.20892/j.issn.2095-3941. 2017.0112.5.     Wei X Liu N Wang XW Ji J. Genomics Studies in Hepatocellular Carcinoma via Next-Generation Sequencing. In: Precision Molecular Pathology of Liver Cancer. Editor: Chen Liu. Publishers: Springer Nature. (Book Chapter:Chapter 4). 2017 In press 978-3-319-68080-4.2016年：     Zhao L Wong LL Shi X Ji J.Should Dysplastic Nodules and Regenerative Nodules Be Regarded as Premalignant Lesions and Treated?Hepatology.2016Oct;64(4):1370.doi: 10.1002/hep.28444.2015年：1.       Lu YY Xu W Ji J Feng D Sourbier C Yang Y Li C Qu J Zeng Z Wang C Chang X Chen Y Mishra A Xu M Lee MJ Trepel J Linehan WM Wang XW Yang Y Neckers L. Alternative splicing of the cell-fate determinant Numb in hepatocellular carcinoma. Hepatology 2015. doi: 10.1002/hep.27923. 2.       Li D Kang N Ji J Zhan Q. BRCA1 regulates transforming growth factor-β (TGF-β1) signaling through Gadd45a by enhancing the protein stability of Smad4. Mol Oncol. 2015. doi: 10.1016/j.molonc. Epub ahead of print3.       Ji J# Zheng X Forgues M Yamashita T Wauthier EL Reid LM Wen X Song Y Wei JS Khan J Thorgeirsson SS Wang XW#. Identification of microRNAs specific for epithelial cell adhesion molecule-positive tumor cells in hepatocellular carcinoma. Hepatology 62: 829-40 2015. (#co-corresponding author)4.       Tao J^ Ji J^ Li X^ Wu H Wang XW Calvisi DF Song G Chen X. Distinct contribution of microRNAs in different oncogene induced liver cancer formation. Oncotarget 6: 6977-6988 2015. (^co-first author)2014年及之前：5.       Wong L Ogihara M Ji J Tsai N. The Changing Characteristics of Hepatocellular Cancer in Hawaii Over Time. American Journal of Surgery 210: 146-152 2014.6.       Parpart S Roessler S Dong F Rao1 B Takai A Ji J Qin LX Ye QH Jia HL Tang ZY Wang XW. Modulation of miR-29 Expression by Alpha-fetoprotein is linked to the Hepatocellular Carcinoma Epigenome. Hepatology 60: 872-883 2014.7.       Sharma A Fonseca LL Rajani C Yanagida JK Endo Y Cline JM Stone JC Ji J Ramos JW and Lorenzo PS. Targeted deletion of RasGRP1impairs Skin tumorigenesis. Carcinogenesis 35: 1084-1091 2014.8.       Ji J# Yu L Yu Z Forgues M Uenishi K Kubo S Zhou J Fan J Tang ZY Fu S Zhu H Jin JG Sun HC Wang XW#. Development of a miR-26 Companion Diagnostic Test for Adjuvant Interferon-alpha Therapy in Hepatocellular Carcinoma. International Journal of Biological Sciences 9: 303-312 2013. (#co-corresponding author)9.       Budhu A Roessler S Zhao X Yu Z Forgues M Ji J Karoly E Qin LX Ye QH Jia HL Fan J Sun HC Tang ZY Wang XW. Integrated Metabolite and Gene Expression Profiles Identify Lipid Biomarkers Associated with Progression of Hepatocellular Carcinoma and Patient Outcomes. Gastroenterology  144: 1066-1075 2013.10.    Ji J and Wang XW. Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Seminars in Oncology 39: 461-72 2012.11.    Ji J and Wang XW. Identification of cancer stem cell-related microRNAs in hepatocellular carcinoma. In: Liver Stem Cells: Methods and Protocols. Editor: Takahiro Ochiya. Publishers: Human Press. (Chapter 14) 163-75. 2012.12.    Oishi N Kumar MR Roessler S Ji J Forgues M Budhu A Zhao X Andersen JB Ye QH Jia HL Qin LX Yamashita T Woo HG Kim YJ Kaneko S Tang ZY Thorgeirsson SS Wang XW. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of mir-200c and EMT in intrahepatic cholangiocarcinoma. Hepatology 56: 1792-1803 2012.13.    Roessler S Long EL Budhu A Chen Y Zhao X Ji J Walker R Jia HL Ye QH Qin LX Tang ZY He P Hunter KW Thorgeirsson SS Meltzer PS Wang XW. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology 142: 957-966 2012.14.    Ji J and Wang XW. MicroRNAs in Hepatocellular Carcinoma. In: MicroRNAs in Cancer Translational Research. Editor: William C.S. Cho. Publishers: Springer. (Chapter 7) 163-188 2011.15.    Kim HS Vassilopoulos A Wang RH Lahusen T Xiao Z Xu X Li C Veenstra TD Li B Yu H Ji J Wang XW Park SH Cha YI Gius D and Deng CX. SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell 20: 487-499 2011.16.    Ji J Yamashita T Wang XW. Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma.  Cell and Biosciences 1 2011.17.    Ji J Wu K Wu M Zhan Q. p53 functional activation is independent of its genotype in five esophageal squamous cell carcinoma cell lines. Frontiers of Medicine in China 4: 412-418 2010.18.    Ji J^ Zhao L^ Budhu A Forgues M Jia HL Qin LX Ye QH Yu J Shi X Tang ZY Wang XW. Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. Journal of Hepatology 52: 690-697 2010. (co-first author^)19.    Wang XW Ji J Budhu A Sun HC. MicroRNA analysis for outcome prediction in hepatitis B virus-related liver cancer (Author Reply). Gastroenterology 4: 1626-1627. 201020.    Budhu A Ji J and Wang XW. The clinical potential of microRNAs. Journal of Hematology and Oncology 3: 37 2010.21.    Ji J and Wang XW. A Yin-Yang balancing act of the lin28/let-7 link in tumorigenesis. (Invited Commentary Article) Journal of Hepatology 53: 974-5 2010.22.    Ji J and Wang XW. New kids on the block: Diagnostic and prognostic microRNAs in hepatocellular carcinoma. Cancer Biology & Therapy 8: 1686-1693 2009.23.    Ji J Wang XW. What is the relationship among microRNA-181 epithelial cell-adhesion molecule (EpCAM) and beta-catenin in hepatic cancer stem cells (Author Reply). Hepatology 50: 2048 2009.24.    Ji J Shi J Budhu A Yu Z Forgues M Roessler S Ambs S Chen Y Meltzer PS Croce CM Qin LX Man K Lo CM Lee J Ng IO Fan J Tang ZY Sun HC Wang XW.  MicroRNA expression survival and response to interferon in men and women with liver cancer. New England Journal of Medicine 361: 1437-1447 2009.25.    Ji J Yamashita T Budhu A Forgues M Jia H Li C Deng C Wauthier E Reid LM Ye Q Qin LX Yang W Wang HY Tang ZY Croce C Wang XW. Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 50: 472-480 2009.26.    Yamashita T Ji J Budhu A Forgues M Yang W Wang HY Jia H Ye Q Qin LX Wauthier E Reid LM Minato H Honda M Kaneko S Tang ZY Wang XW. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136:1012-1024 2009.27.    Budhu A Ji J and Wang XW. The genomics of human hepatocellular carcinoma. In: Hepatocellular Cancer Diagnosis and Treatment second edition. Editor: B. Carr. Publishers: Humana Press NY. (Chapter 5) 131-182 2009.28.    Ji J^ Liu R^ Tong T Song Y Jin S Wu M Zhan Q. Gadd45a regulates beta-catenin distribution and maintains cell-cell adhesion/contact. Oncogene 26: 6396-6405 2007. (co-first author^)29.    Ji J Wu M Zhan Q. Gadd45a Function in Suppressing Cell Transformation and Tumor Malignancy.  Progress in Biochemistry and Biophysics 33: 1146-1153 2006.30.    Tong T^ Ji J^ Jin S Li X Fan W Song Y Wang M Liu Z Wu M Zhan Q. Gadd45a expression induces Bim dissociation from the cytoskeleton and translocation to mitochondria. Mol Cell Biol 25: 4488-4500 2005. (co-first author^)31.    姬峻芳 詹启敏，吴旻. Bcl-2与p53之间的相互作用. 医学分子生物学杂志 2005年02期: 102-4.32.    Ji J Zhao L Wang X Zhou C Ding F Su L Zhang C Mao X Wu M Liu Z. Differential Expression of S100 Gene Family in Human Esophageal Squamous Cell Carcinoma. J Cancer Res Clin Oncol 130: 480-486 2004.33.    Luo A Kong J Hu G Liew CC Xiong M Wang X Ji J Wang T Zhi H Wu M Liu Z. Discovery of Ca2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23: 1291-1299 200434.    姬峻芳，刘芝华，赵立群。S100蛋白家族与肿瘤. 国外医学肿瘤学分册 2002年04期: 261-3.课题组成员: 